← All workstreams
Drug policy governance

Reducing drug-related deaths

Drug-related deaths and harms persistently reach all-time highs in the UK. We campaign for an evidence-based, public-health approach that treats every one of those deaths as preventable.

What we believe

The current approach to drug control is unscientific and ineffective. Legislation should classify drugs according to the scientific evidence on their relative potential for harm — and be judged on whether it reduces harm in practice.

Harm-reduction measures save lives. As our Chair told Parliament: "Continuity is not a strategy; it is a guarantee of further avoidable loss. Every single one of those deaths was preventable."

What we've done

NOV 2025

Chair Charlotte Nichols MP secured and led an adjournment debate on drug-related deaths, noting deaths in England and Wales had risen for the 12th consecutive year.

2025

Patron Jim Shannon MP led a well-attended Westminster Hall debate on reducing drug deaths, following the latest ONS figures.

2025

Responded to the Government's consultation on expanding naloxone access, highlighting the gap left by naloxone's Prescription-Only status.

EARLIER

Our report Making UK Drug Policy a Success (23 recommendations) influenced the Government's 10-Year Drug Strategy; our ACMD survey preceded a recruitment drive that doubled ACMD membership.